| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.17 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.099 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |